Bridge Biotherapeutics, Inc. is an enterprise based in South Korea. Its main office is in Seongnam. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. Bridge Biotherapeutics, Inc. was incorporated on September 17, 2015. There are currently 11 - 50 (2025) people employed by Bridge Biotherapeutics, Inc.. From the latest financial highlights, Bridge Biotherapeutics, Inc. reported a net sales revenue increase of 733.33% in Q3C2025. Its’ total assets recorded a growth of 47.48%. The net profit margin of Bridge Biotherapeutics, Inc. increased by 1313983.39% in 2025.
Headquarters
303, 58, Pangyo-Ro 258Beon-Gil, Bundang-Gu, Seongnam-Si, Gyeonggi-Do
Seongnam; Gyeonggi;
Contact Details: Purchase the Bridge Biotherapeutics, Inc. report to view the information.
Website: http://www.bridgebiorx.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service